Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Ocumension Therapeutics ( (HK:1477) ) has issued an announcement.
Ocumension Therapeutics has announced the composition of its board of directors, highlighting the roles and functions of its members. This structural update is poised to impact the company’s governance and strategic direction, potentially influencing its operations and positioning within the ophthalmology sector.
More about Ocumension Therapeutics
Ocumension Therapeutics is a company incorporated in the Cayman Islands, focusing on the pharmaceutical industry with a primary emphasis on therapies and treatments related to ophthalmology.
YTD Price Performance: -17.33%
Average Trading Volume: 1,438,654
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$3.07B
For an in-depth examination of 1477 stock, go to TipRanks’ Stock Analysis page.